日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Reviewed article: Paiva RFPS, Maia ALO, Martins JBC. Occurrences, human harm and years of life lost due to natural disasters in the state of Rio de Janeiro, Brazil, 2010-2022: a cohort study. Epidemiol Serv Saude. 2025;34:e20240412. 10.1590/S2237-96222025v34e20240412.en

综述文章：Paiva RFPS、Maia ALO、Martins JBC。《2010-2022年巴西里约热内卢州自然灾害的发生率、人员伤亡及生命损失年数：一项队列研究》。《流行病学服务与健康》。2025;34:e20240412。10.1590/S2237-96222025v34e20240412.en

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0323062
Henner, David E; Drambarean, Beatrice; Gerbeling, Teresa M; Kendrick, Jessica B; Kendrick, William T; Koester-Wiedemann, Lisa; Nickolas, Thomas L; Rastogi, Anjay; Rauf, Anis A; Dyson, Brenda; Singer, Michael C; Desai, Pooja; Fox, Kathleen M; Cheng, Sunfa; Goodman, William; Villa-Campos, Oswaldo
发表日期：2025
文献求助 收藏

Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel

美国继发性甲状旁腺功能亢进症的诊疗实践模式：一项改良德尔菲小组的研究结果

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0266281
Henner, David E; Drambarean, Beatrice; Gerbeling, Teresa M; Kendrick, Jessica B; Kendrick, William T; Koester-Wiedemann, Lisa; Nickolas, Thomas L; Rastogi, Anjay; Rauf, Anis A; Dyson, Brenda; Singer, Michael C; Desai, Pooja; Fox, Kathleen M; Cheng, Sunfa; Goodman, William
发表日期：2025
文献求助 收藏

Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial

依瑞奈单抗治疗日本发作性和慢性偏头痛患者的长期疗效和安全性：一项随机试验28周开放标签治疗期的结果

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2022-068616
Hirata, Koichi; Takeshima, Takao; Sakai, Fumihiko; Numachi, Yotaro; Yoshida, Ryuji; Koukakis, Reija; Hasebe, Miki; Yui, Daishi; da Silva Lima, Gabriel Paiva; Cheng, Sunfa
偏头痛
神经科学
发表日期：2023
文献求助 收藏

Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis

依瑞奈单抗治疗既往预防性治疗失败的慢性偏头痛患者的长期疗效和安全性：一项亚组分析

期刊:Headache
影响因子:4
doi:10.1111/head.14313
Ashina, Messoud; Tepper, Stewart J; Brandes, Jan Lewis; Reuter, Uwe; Boudreau, Guy P; Weatherall, Mark; Gantenbein, Andreas R; Doležil, David; Klatt, Jan; Wang, Andrea; Karanam, Ananda Krishna; Cheng, Sunfa; Mikol, Daniel D
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Etelcalcetide Versus Cinacalcet in Hemodialysis Patients in the United States: A Facility Calcimimetic Approach to Assess Real-World Effectiveness

美国血液透析患者中依替卡塞肽与西那卡塞的比较：一种评估真实世界疗效的机构钙敏感受体激动剂方法

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2022.100475
Karaboyas, Angelo; Muenz, Daniel; Hwang, Yunji; Goodman, William; Cheng, Sunfa; Desai, Pooja; Fox, Kathleen M; Robinson, Bruce M; Pisoni, Ronald L
信号转导
发表日期：2022
文献求助 收藏

Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies

依瑞奈单抗预防日本患者偏头痛的早期疗效：两项随机、双盲、安慰剂对照研究的分析

期刊:Brain and Behavior
影响因子:2.7
doi:10.1002/brb3.2526
Hirata, Koichi; Takeshima, Takao; Sakai, Fumihiko; Imai, Noboru; Matsumori, Yasuhiko; Tatsuoka, Yoshihisa; Numachi, Yotaro; Yoshida, Ryuji; Peng, Cheng; Mikol, Daniel D; Lima, Gabriel Paiva da Silva; Cheng, Sunfa
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial

依瑞奈单抗治疗既往预防性治疗失败或正在接受预防性治疗的日本偏头痛患者的疗效和安全性：一项3期随机试验的亚组分析

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01313-8
Hirata, Koichi; Sakai, Fumihiko; Takeshima, Takao; Imai, Noboru; Matsumori, Yasuhiko; Yoshida, Ryuji; Numachi, Yotaro; Peng, Cheng; Mikol, Daniel D; Cheng, Sunfa
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials

依瑞奈单抗治疗可减少急性偏头痛特异性和非特异性药物的使用：发作性偏头痛和慢性偏头痛临床试验的事后分析

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01292-w
Tepper, Stewart J; Ashina, Messoud; Reuter, Uwe; Hallström, Yngve; Broessner, Gregor; Bonner, Jo H; Picard, Hernan; Cheng, Sunfa; Chou, Denise E; Zhang, Feng; Klatt, Jan; Mikol, Daniel D
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension

使用erenumab治疗后，慢性偏头痛逆转为发作性偏头痛：一项随机、12周、双盲研究和一项52周开放标签扩展研究的事后分析结果

期刊:Cephalalgia
影响因子:4.6
doi:10.1177/0333102420973994
Lipton, Richard B; Tepper, Stewart J; Silberstein, Stephen D; Kudrow, David; Ashina, Messoud; Reuter, Uwe; Dodick, David W; Zhang, Feng; Rippon, Gregory A; Cheng, Sunfa; Mikol, Daniel D
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial

依瑞奈单抗预防偏头痛的长期疗效和安全性：一项随机临床试验5年开放标签治疗阶段的结果

期刊:European Journal of Neurology
影响因子:3.9
doi:10.1111/ene.14715
Ashina, Messoud; Goadsby, Peter J; Reuter, Uwe; Silberstein, Stephen; Dodick, David W; Xue, Fei; Zhang, Feng; Paiva da Silva Lima, Gabriel; Cheng, Sunfa; Mikol, Daniel D
偏头痛
神经科学
发表日期：2021
文献求助 收藏